Auricular vagus nerve stimulation enhances central serotonergic function and inhibits diabetic neuropathy development in Zucker fatty rats
Open Access
- 1 January 2018
- journal article
- research article
- Published by SAGE Publications in Molecular Pain
- Vol. 14
Abstract
Painful neuropathy is a frequent comorbidity in diabetes. Zucker diabetic fatty (fa/fa) rats develop type 2 diabetes spontaneously with aging and show nociceptive hypersensitivity at the age of 13 weeks. In preclinical and clinical studies, the treatment of diabetic neuropathy is challenging, but complementary medicine such as transcutaneous auricular vagus nerve stimulation (taVNS) appears beneficial to the relief of neuropathic pain. However, the mechanism behind the effectiveness of taVNS remains unclear. In this study, we show that daily 30-min taVNS (2/15 Hz, 2 mA) for consecutive 27 days effectively inhibited the development of nociceptive hypersensitivity in Zucker diabetic fatty rats as detected by thermal hyperalgesia and mechanical allodynia in hindpaw. We also demonstrated that this beneficial effect in nociceptive behavior is related to an elevated serotonin (5-HT) plasma concentration and an upregulated expression of 5-HT receptor type 1A (5-HT1AR) in hypothalamus. We conclude that daily 30-min taVNS sessions lessen diabetic neuropathy development by enhancing serotonergic function in genetically diabetes prone individuals.PerspectiveThis article presents taVNS as a new approach to inhibit the development of diabetic neuropathy in genetically prone individuals. This approach could potentially help clinicians who seek to avoid the complication of neuropathic pain in diabetic patient or to relieve the pain if there was one.Keywords
Funding Information
- National Natural Science Foundation of China (81271243)
- National Natural Science Foundation of China (81473780)
- National Natural Science Foundation of China (81571085)
- Sino-German Center for Research Promotion Foundation (GZ 1236)
- The High-level Leading Talent Introduction Program of GDAS (grant number 2016GDASRC-0205)
This publication has 44 references indexed in Scilit:
- Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivativesEuropean Journal of Pharmacology, 2017
- Optimization of Transcutaneous Vagus Nerve Stimulation Using Functional MRINeuromodulation: Technology at the Neural Interface, 2017
- A Correlative Relationship Between Chronic Pain and Insulin Resistance in Zucker Fatty Rats: Role of Downregulation of Insulin ReceptorsThe Journal of Pain, 2016
- Non-invasive Vagus Nerve Stimulation in Healthy Humans Reduces Sympathetic Nerve ActivityBrain Stimulation, 2014
- Transcutaneous Auricular Vagus Nerve Stimulation Protects Endotoxemic Rat from Lipopolysaccharide-Induced InflammationEvidence-Based Complementary and Alternative Medicine, 2012
- The complex role of serotonin and 5-HT receptors in chronic painBehavioural Pharmacology, 2011
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin ReceptorsPharmacological Reviews, 2010
- International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).Pharmacological Reviews, 1994
- Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nervePain, 1994
- Relationship between electroacupuncture analgesia and descending pain inhibitory mechanism of nucleus raphe magnusPain, 1986